HEADER HYDROLASE 18-MAY-11 2YJ6 TITLE CONFORMATIONAL CHANGES IN THE CATALYTIC DOMAIN OF THE CPX-ATPASE COPB- TITLE 2 B UPON NUCLEOTIDE BINDING COMPND MOL_ID: 1; COMPND 2 MOLECULE: COPPER-TRANSPORTING ATPASE; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: RESIDUES 383-645; COMPND 5 EC: 3.6.1.36, 3.6.3.10; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: SULFOLOBUS SOLFATARICUS; SOURCE 3 ORGANISM_TAXID: 273057; SOURCE 4 STRAIN: P2; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_VECTOR: PET27 KEYWDS HYDROLASE, P-TYPE ATPASE, HEAVY METAL TRANSLOCATION EXPDTA X-RAY DIFFRACTION AUTHOR C.VOELLMECKE,C.SCHLICKER,M.LUEBBEN,E.HOFMANN REVDAT 2 20-DEC-23 2YJ6 1 REMARK REVDAT 1 30-MAY-12 2YJ6 0 JRNL AUTH C.VOELLMECKE,C.SCHLICKER,M.LUEBBEN,E.HOFMANN JRNL TITL CONFORMATIONAL CHANGES IN THE CATALYTIC DOMAIN OF THE JRNL TITL 2 CPX-ATPASE COPB-B UPON NUCLEOTIDE BINDING JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 2.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE: 1.6.4_486) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 48.33 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.990 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 29664 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.242 REMARK 3 R VALUE (WORKING SET) : 0.239 REMARK 3 FREE R VALUE : 0.287 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1484 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 48.3456 - 4.8913 1.00 2635 139 0.2185 0.2298 REMARK 3 2 4.8913 - 3.8829 1.00 2593 137 0.1996 0.2405 REMARK 3 3 3.8829 - 3.3922 1.00 2559 134 0.2457 0.2785 REMARK 3 4 3.3922 - 3.0821 1.00 2580 136 0.2581 0.3023 REMARK 3 5 3.0821 - 2.8612 1.00 2545 134 0.2573 0.3362 REMARK 3 6 2.8612 - 2.6925 1.00 2555 135 0.2715 0.3463 REMARK 3 7 2.6925 - 2.5577 1.00 2544 134 0.2745 0.3946 REMARK 3 8 2.5577 - 2.4464 1.00 2524 132 0.2716 0.3332 REMARK 3 9 2.4464 - 2.3522 1.00 2582 136 0.2789 0.3425 REMARK 3 10 2.3522 - 2.2710 1.00 2515 133 0.2589 0.3978 REMARK 3 11 2.2710 - 2.2000 1.00 2548 134 0.2641 0.3360 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.30 REMARK 3 SHRINKAGE RADIUS : 1.06 REMARK 3 K_SOL : 0.30 REMARK 3 B_SOL : 38.79 REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.420 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 30.220 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 40.18 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 42.40 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.56860 REMARK 3 B22 (A**2) : -5.34240 REMARK 3 B33 (A**2) : 6.91100 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -1.85330 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.009 3867 REMARK 3 ANGLE : 1.280 5242 REMARK 3 CHIRALITY : 0.084 629 REMARK 3 PLANARITY : 0.004 654 REMARK 3 DIHEDRAL : 18.685 1432 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2YJ6 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 18-MAY-11. REMARK 100 THE DEPOSITION ID IS D_1290048335. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X10SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.00000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 29666 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.200 REMARK 200 RESOLUTION RANGE LOW (A) : 48.330 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 6.600 REMARK 200 R MERGE (I) : 0.05000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 21.2500 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.30 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 7.00 REMARK 200 R MERGE FOR SHELL (I) : 0.35000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 5.820 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 2IYE REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 52.36 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.58 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M NA/MES PH 6.5, 0.2 M AMMONIUM REMARK 280 CHLORIDE, 15 % PEG 6000 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 26.95000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 ENGINEERED RESIDUE IN CHAIN A, ASP 416 TO ASN REMARK 400 ENGINEERED RESIDUE IN CHAIN B, ASP 416 TO ASN REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 383 REMARK 465 GLY A 608 REMARK 465 VAL A 609 REMARK 465 ASP A 610 REMARK 465 ARG A 635 REMARK 465 LYS A 636 REMARK 465 ARG A 637 REMARK 465 LEU A 638 REMARK 465 SER A 639 REMARK 465 ASN A 640 REMARK 465 ALA A 641 REMARK 465 ILE A 642 REMARK 465 PRO A 643 REMARK 465 SER A 644 REMARK 465 ASN A 645 REMARK 465 MET B 383 REMARK 465 LYS B 636 REMARK 465 ARG B 637 REMARK 465 LEU B 638 REMARK 465 SER B 639 REMARK 465 ASN B 640 REMARK 465 ALA B 641 REMARK 465 ILE B 642 REMARK 465 PRO B 643 REMARK 465 SER B 644 REMARK 465 ASN B 645 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LEU A 385 CG CD1 CD2 REMARK 470 LYS A 399 CG CD CE NZ REMARK 470 SER A 401 OG REMARK 470 LYS A 408 CG CD CE NZ REMARK 470 SER A 477 OG REMARK 470 ILE A 479 CD1 REMARK 470 LYS A 494 CG CD CE NZ REMARK 470 ASN A 497 CG OD1 ND2 REMARK 470 LYS A 524 CG CD CE NZ REMARK 470 TYR A 526 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 LEU A 527 CG CD1 CD2 REMARK 470 GLU A 528 CG CD OE1 OE2 REMARK 470 LEU A 530 CG CD1 CD2 REMARK 470 ASN A 532 CG OD1 ND2 REMARK 470 GLU A 533 CG CD OE1 OE2 REMARK 470 LYS A 544 CG CD CE NZ REMARK 470 GLU A 550 CG CD OE1 OE2 REMARK 470 LYS A 553 CG CD CE NZ REMARK 470 ASN A 556 CG OD1 ND2 REMARK 470 ILE A 557 CD1 REMARK 470 LYS A 575 CG CD CE NZ REMARK 470 ILE A 611 CG1 CG2 CD1 REMARK 470 ASN A 614 CG OD1 ND2 REMARK 470 ILE A 625 CG1 CG2 CD1 REMARK 470 LEU A 629 CG CD1 CD2 REMARK 470 ILE A 632 CG1 CG2 CD1 REMARK 470 LYS B 399 CG CD CE NZ REMARK 470 LYS B 408 CG CD CE NZ REMARK 470 SER B 477 OG REMARK 470 ILE B 479 CD1 REMARK 470 GLU B 496 CG CD OE1 OE2 REMARK 470 ASN B 497 CG OD1 ND2 REMARK 470 ASN B 499 CG OD1 ND2 REMARK 470 LEU B 527 CG CD1 CD2 REMARK 470 ASN B 532 CB CG OD1 ND2 REMARK 470 GLU B 533 CG CD OE1 OE2 REMARK 470 ILE B 557 CD1 REMARK 470 LYS B 575 CG CD CE NZ REMARK 470 ASN B 614 CG OD1 ND2 REMARK 470 VAL B 615 CG1 CG2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 417 -70.07 -45.41 REMARK 500 ASP A 472 36.80 35.28 REMARK 500 ILE A 479 -59.31 -134.34 REMARK 500 ASP A 487 -7.47 77.30 REMARK 500 ASN A 497 -82.36 -79.39 REMARK 500 ASN A 522 -108.49 -51.55 REMARK 500 LEU A 523 176.95 143.74 REMARK 500 ASP A 525 46.26 -70.29 REMARK 500 GLU A 533 -153.11 -164.70 REMARK 500 ASP A 588 -103.84 -120.16 REMARK 500 VAL A 590 -116.65 -110.10 REMARK 500 ASN A 591 43.92 -74.62 REMARK 500 ASP A 592 2.10 -151.03 REMARK 500 LYS A 613 29.88 -65.01 REMARK 500 ASN A 614 -89.08 31.58 REMARK 500 ILE B 479 -64.66 -132.94 REMARK 500 ASN B 497 -90.45 -86.92 REMARK 500 ASN B 498 -72.47 -31.37 REMARK 500 ASN B 499 -7.93 134.50 REMARK 500 ASN B 522 32.55 72.61 REMARK 500 ASP B 525 27.33 -65.14 REMARK 500 ASP B 525 27.91 -65.14 REMARK 500 TYR B 526 42.71 -100.73 REMARK 500 ASN B 532 21.74 -72.72 REMARK 500 GLU B 533 -167.42 150.92 REMARK 500 ASP B 588 118.25 -174.06 REMARK 500 VAL B 615 -131.12 90.39 REMARK 500 ALA B 616 86.85 47.90 REMARK 500 ASN B 623 18.83 58.84 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE A99 A 1636 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE A99 B 1636 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PO4 B 1637 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2YJ5 RELATED DB: PDB REMARK 900 CONFORMATIONAL CHANGES IN THE CATALYTIC DOMAIN OF THE CPX-ATPASE REMARK 900 COPB-B UPON NUCLEOTIDE BINDING REMARK 900 RELATED ID: 2YJ4 RELATED DB: PDB REMARK 900 CONFORMATIONAL CHANGES IN THE CATALYTIC DOMAIN OF THE CPX-ATPASE REMARK 900 COPB-B UPON NUCLEOTIDE BINDING REMARK 900 RELATED ID: 2IYE RELATED DB: PDB REMARK 900 STRUCTURE OF CATALYTIC CPX-ATPASE DOMAIN COPB-B REMARK 900 RELATED ID: 2YJ3 RELATED DB: PDB REMARK 900 CONFORMATIONAL CHANGES IN THE CATALYTIC DOMAIN OF THE CPX-ATPASE REMARK 900 COPB-B UPON NUCLEOTIDE BINDING DBREF 2YJ6 A 383 645 UNP Q97UU7 Q97UU7_SULSO 383 645 DBREF 2YJ6 B 383 645 UNP Q97UU7 Q97UU7_SULSO 383 645 SEQADV 2YJ6 ASN A 416 UNP Q97UU7 ASP 416 ENGINEERED MUTATION SEQADV 2YJ6 ASN B 416 UNP Q97UU7 ASP 416 ENGINEERED MUTATION SEQRES 1 A 263 MET ALA LEU SER LEU TYR GLU LYS MET LEU HIS LYS GLY SEQRES 2 A 263 MET ILE ILE LYS ASN SER ASN VAL TYR GLU LYS ILE LYS SEQRES 3 A 263 GLU ILE ASP THR ILE ILE PHE ASN LYS THR GLY THR LEU SEQRES 4 A 263 THR TYR GLY THR PRO ILE VAL THR GLN PHE ILE GLY ASP SEQRES 5 A 263 SER LEU SER LEU ALA TYR ALA ALA SER VAL GLU ALA LEU SEQRES 6 A 263 SER SER HIS PRO ILE ALA LYS ALA ILE VAL LYS TYR ALA SEQRES 7 A 263 LYS GLU GLN GLY VAL LYS ILE LEU GLU VAL LYS ASP PHE SEQRES 8 A 263 LYS GLU ILE SER GLY ILE GLY VAL ARG GLY LYS ILE SER SEQRES 9 A 263 ASP LYS ILE ILE GLU VAL LYS LYS ALA GLU ASN ASN ASN SEQRES 10 A 263 ASP ILE ALA VAL TYR ILE ASN GLY GLU PRO ILE ALA SER SEQRES 11 A 263 PHE ASN ILE SER ASP VAL PRO ARG PRO ASN LEU LYS ASP SEQRES 12 A 263 TYR LEU GLU LYS LEU LYS ASN GLU GLY LEU LYS ILE ILE SEQRES 13 A 263 ILE LEU SER GLY ASP LYS GLU ASP LYS VAL LYS GLU LEU SEQRES 14 A 263 SER LYS GLU LEU ASN ILE GLN GLU TYR TYR SER ASN LEU SEQRES 15 A 263 SER PRO GLU ASP LYS VAL ARG ILE ILE GLU LYS LEU LYS SEQRES 16 A 263 GLN ASN GLY ASN LYS VAL LEU MET ILE GLY ASP GLY VAL SEQRES 17 A 263 ASN ASP ALA ALA ALA LEU ALA LEU ALA ASP VAL SER VAL SEQRES 18 A 263 ALA MET GLY ASN GLY VAL ASP ILE SER LYS ASN VAL ALA SEQRES 19 A 263 ASP ILE ILE LEU VAL SER ASN ASP ILE GLY THR LEU LEU SEQRES 20 A 263 GLY LEU ILE LYS ASN ARG LYS ARG LEU SER ASN ALA ILE SEQRES 21 A 263 PRO SER ASN SEQRES 1 B 263 MET ALA LEU SER LEU TYR GLU LYS MET LEU HIS LYS GLY SEQRES 2 B 263 MET ILE ILE LYS ASN SER ASN VAL TYR GLU LYS ILE LYS SEQRES 3 B 263 GLU ILE ASP THR ILE ILE PHE ASN LYS THR GLY THR LEU SEQRES 4 B 263 THR TYR GLY THR PRO ILE VAL THR GLN PHE ILE GLY ASP SEQRES 5 B 263 SER LEU SER LEU ALA TYR ALA ALA SER VAL GLU ALA LEU SEQRES 6 B 263 SER SER HIS PRO ILE ALA LYS ALA ILE VAL LYS TYR ALA SEQRES 7 B 263 LYS GLU GLN GLY VAL LYS ILE LEU GLU VAL LYS ASP PHE SEQRES 8 B 263 LYS GLU ILE SER GLY ILE GLY VAL ARG GLY LYS ILE SER SEQRES 9 B 263 ASP LYS ILE ILE GLU VAL LYS LYS ALA GLU ASN ASN ASN SEQRES 10 B 263 ASP ILE ALA VAL TYR ILE ASN GLY GLU PRO ILE ALA SER SEQRES 11 B 263 PHE ASN ILE SER ASP VAL PRO ARG PRO ASN LEU LYS ASP SEQRES 12 B 263 TYR LEU GLU LYS LEU LYS ASN GLU GLY LEU LYS ILE ILE SEQRES 13 B 263 ILE LEU SER GLY ASP LYS GLU ASP LYS VAL LYS GLU LEU SEQRES 14 B 263 SER LYS GLU LEU ASN ILE GLN GLU TYR TYR SER ASN LEU SEQRES 15 B 263 SER PRO GLU ASP LYS VAL ARG ILE ILE GLU LYS LEU LYS SEQRES 16 B 263 GLN ASN GLY ASN LYS VAL LEU MET ILE GLY ASP GLY VAL SEQRES 17 B 263 ASN ASP ALA ALA ALA LEU ALA LEU ALA ASP VAL SER VAL SEQRES 18 B 263 ALA MET GLY ASN GLY VAL ASP ILE SER LYS ASN VAL ALA SEQRES 19 B 263 ASP ILE ILE LEU VAL SER ASN ASP ILE GLY THR LEU LEU SEQRES 20 B 263 GLY LEU ILE LYS ASN ARG LYS ARG LEU SER ASN ALA ILE SEQRES 21 B 263 PRO SER ASN HET A99 A1636 42 HET A99 B1636 42 HET PO4 B1637 5 HETNAM A99 5'-O-[(S)-HYDROXY{[(R)-HYDROXY({(S)-HYDROXY[(1S)-1-(2- HETNAM 2 A99 NITROPHENYL)ETHOXY]PHOSPHORYL}OXY) HETNAM 3 A99 PHOSPHORYL]OXY}PHOSPHORYL]ADENOSINE HETNAM PO4 PHOSPHATE ION FORMUL 3 A99 2(C18 H23 N6 O15 P3) FORMUL 5 PO4 O4 P 3- FORMUL 6 HOH *31(H2 O) HELIX 1 1 SER A 386 GLY A 395 1 10 HELIX 2 2 ASN A 402 GLU A 409 1 8 HELIX 3 3 ASP A 434 ALA A 446 1 13 HELIX 4 4 HIS A 450 GLN A 463 1 14 HELIX 5 5 ASP A 525 GLU A 533 1 9 HELIX 6 6 LYS A 544 LEU A 555 1 12 HELIX 7 7 SER A 565 ASN A 579 1 15 HELIX 8 8 ASP A 592 ALA A 599 1 8 HELIX 9 9 ILE A 625 LYS A 633 1 9 HELIX 10 10 SER B 386 LYS B 394 1 9 HELIX 11 11 ASN B 402 GLU B 409 1 8 HELIX 12 12 ASP B 434 ALA B 446 1 13 HELIX 13 13 HIS B 450 GLY B 464 1 15 HELIX 14 14 TYR B 526 ASN B 532 1 7 HELIX 15 15 LYS B 544 LEU B 555 1 12 HELIX 16 16 SER B 565 ASN B 579 1 15 HELIX 17 17 GLY B 589 ASN B 591 5 3 HELIX 18 18 ASP B 592 ALA B 599 1 8 HELIX 19 19 ASP B 624 ARG B 635 1 12 SHEET 1 AA 7 MET A 396 ILE A 398 0 SHEET 2 AA 7 ILE A 618 LEU A 620 -1 O ILE A 619 N ILE A 397 SHEET 3 AA 7 VAL A 601 MET A 605 1 O SER A 602 N ILE A 618 SHEET 4 AA 7 VAL A 583 GLY A 587 1 O VAL A 583 N VAL A 601 SHEET 5 AA 7 THR A 412 ASN A 416 1 O THR A 412 N LEU A 584 SHEET 6 AA 7 LYS A 536 LEU A 540 1 O LYS A 536 N ILE A 413 SHEET 7 AA 7 TYR A 560 TYR A 561 1 N TYR A 561 O ILE A 539 SHEET 1 AB 6 ILE A 427 ILE A 432 0 SHEET 2 AB 6 GLU A 508 SER A 516 -1 O SER A 512 N ILE A 432 SHEET 3 AB 6 ILE A 501 ILE A 505 -1 O ILE A 501 N PHE A 513 SHEET 4 AB 6 LYS A 488 LYS A 494 -1 O GLU A 491 N TYR A 504 SHEET 5 AB 6 GLY A 480 ILE A 485 -1 O VAL A 481 N VAL A 492 SHEET 6 AB 6 LYS A 471 LYS A 474 -1 O LYS A 471 N LYS A 484 SHEET 1 BA 7 MET B 396 ILE B 398 0 SHEET 2 BA 7 ILE B 618 LEU B 620 -1 O ILE B 619 N ILE B 397 SHEET 3 BA 7 VAL B 601 MET B 605 1 O SER B 602 N ILE B 618 SHEET 4 BA 7 VAL B 583 GLY B 587 1 O VAL B 583 N VAL B 601 SHEET 5 BA 7 THR B 412 ASN B 416 1 O THR B 412 N LEU B 584 SHEET 6 BA 7 LYS B 536 LEU B 540 1 O LYS B 536 N ILE B 413 SHEET 7 BA 7 TYR B 560 TYR B 561 1 N TYR B 561 O ILE B 539 SHEET 1 BB 6 ILE B 427 ILE B 432 0 SHEET 2 BB 6 GLU B 508 SER B 516 -1 O SER B 512 N ILE B 432 SHEET 3 BB 6 ILE B 501 ILE B 505 -1 O ILE B 501 N PHE B 513 SHEET 4 BB 6 LYS B 488 LYS B 494 -1 O GLU B 491 N TYR B 504 SHEET 5 BB 6 GLY B 480 ILE B 485 -1 O VAL B 481 N VAL B 492 SHEET 6 BB 6 LYS B 471 ILE B 476 -1 O LYS B 471 N LYS B 484 SITE 1 AC1 13 THR A 418 GLY A 424 PRO A 426 GLU A 445 SITE 2 AC1 13 HIS A 450 ILE A 452 GLY A 478 ILE A 479 SITE 3 AC1 13 VAL A 492 LYS A 494 ILE A 501 ASP A 517 SITE 4 AC1 13 HOH A2011 SITE 1 AC2 9 THR B 418 GLY B 424 PRO B 426 GLU B 445 SITE 2 AC2 9 HIS B 450 ILE B 452 GLY B 478 ILE B 479 SITE 3 AC2 9 LYS B 494 SITE 1 AC3 4 GLU B 545 TYR B 561 SER B 562 HOH B2017 CRYST1 69.560 53.900 78.950 90.00 98.24 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014376 0.000000 0.002082 0.00000 SCALE2 0.000000 0.018553 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012798 0.00000